Skip to main content
. Author manuscript; available in PMC: 2020 Mar 26.
Published in final edited form as: Biochemistry. 2019 Mar 11;58(12):1689–1697. doi: 10.1021/acs.biochem.8b01303

Figure 3.

Figure 3.

(A) Delivery of DTZ or AkaLumine at the indicated doses via i.v. or i.p. to B6 albino mice or BALB/c mice, yielding low background. Luminescence radiance is displayed in the same scale as in Figures 4A and4B. (B) Representative bioluminescence images of BALB/c mice (from left to right: blank, i.v. injection of DTZ, i.p. injection of DTZ, and i.v. or i.p. injection of DTZ after i.v. injection of Antares2-expressing HEK 293T cells). To show the existence of background signals, luminescence radiance is displayed in a compressed scale compared to Figures 3A and4AB.